RxDoctor Payments Data

Monique Casey-Bolden, MD

Family Medicine · Dyersburg, TNNPI 1710985858

Payments from drug & device makers

$1,698in general payments, 2019–2025

Across 90 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$248
  • Boehringer Ingelheim$227
  • AstraZeneca$179
  • Johnson & Johnson$170
  • Novo Nordisk$169
  • Merck$133
  • plus $573 from 13 others

What the payments were for

  • Food & beverage$1,695100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,698 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$49,817
Medicare patients
230
Services billed
1,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$38,753
FarxigaDapagliflozin Propanediol52$38,173
EliquisApixaban23$25,189
JanumetSitagliptin Phos/Metformin Hcl30$19,094
XareltoRivaroxaban20$15,786
JanuviaSitagliptin Phosphate18$12,730
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$11,830
TradjentaLinagliptin18$10,926
Janumet XrSitagliptin Phos/Metformin Hcl14$10,545
AbrysvoRsv Vacc, Pref A And Pref B/Pf21$6,186
ShingrixVaricella-Zoster Ge/As01b/Pf29$5,885
Solifenacin Succinate37$5,270
Atorvastatin Calcium228$3,239
Nebivolol Hcl34$2,728
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet, Januvia, Janumet Xr$133$42,36862 claims
Novo NordiskOzempic$169$38,75335 claims
AstraZenecaFarxiga$179$38,17352 claims
PfizerEliquis, Abrysvo$15$31,37644 claims
Johnson & JohnsonXarelto$170$15,78620 claims
Boehringer IngelheimTradjenta$227$10,92618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Dyersburg

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →